Edwards Lifesciences Corporation develops first KONECT RESILIA Aortic Valved Conduit (AVC), the first ready-to-implant solution for bio-Bentall procedures, a complex surgery that involves replacement of a patient's aortic valve, aortic root and the ascending aorta.
KONECT device is designed with advanced RESILIA tissue, which incorporates integrity-preservation technology that may help improve valve durability. The RESILIA tissue technology also allows devices to be stored under dry packaging conditions, facilitating ease of use during patient care.
The KONECT device with advancement offers surgeons a preassembled device with two leading technologies, which can streamline treatment for patients requiring this complex and technical procedure.
U.S. Food and Drug Administration (FDA) grants approval for the for the KONECT RESILIA
Bio-Bental procedure is a complex surgery that involves replacement of a patient’s aortic valve, aortic root and the ascending aorta.
Bio-Bental procedure is a complex surgery that involves replacement of a patient’s aortic valve, aortic root and the ascending aorta.
